
Weight-loss medications may also benefit common medical problem, study finds
Fox News
Glucagon-like peptide-1 (GLP-1) agonists — weight loss medications widely used for type 2 diabetes and obesity — have been found to unexpectedly reduce alcohol consumption as a secondary benefit.
Among the regular drinkers, weekly alcohol intake decreased by 68%, from approximately 23 units of alcohol to around 8 units. "The findings in this study suggest that we may have just found a therapeutic target for alcohol use disorder."
The findings were recently published in the journal Diabetes, Obesity and Metabolism and were also presented last week at the European Congress on Obesity in Spain.
More Related News













